Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED BALANCE SHEETS

v3.22.2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2022
Mar. 31, 2021
Current Assets:    
Cash and cash equivalents $ 22,559 $ 49,533
Accounts receivable, net of allowances of $312 at March 31, 2022 and $314 at March 31, 2021 24,665 20,593
Inventories, net 18,465 11,829
Prepaid expenses and other current assets 5,519 4,953
Total current assets 71,208 86,908
Property, plant, equipment and rental assets, net 18,038 9,630
Non-current portion of accounts receivable 1,212  
Non-current portion of inventories 1,680 1,845
Other assets 8,635 7,639
Total assets 100,773 106,022
Current Liabilities:    
Accounts payable and accrued expenses 25,130 19,767
Accrued salaries and wages 1,147 1,889
Accrued warranty reserve 1,483 5,850
Deferred revenue 9,185 6,374
Current portion of notes payable and lease obligations 675 576
Total current liabilities 37,620 34,456
Deferred revenue - non-current 981 765
Term note payable, net 50,949 52,865
Long-term portion of notes payable and lease obligations 5,809 4,762
Total liabilities 95,359 92,848
Stockholders' Equity:    
Common stock, $.001 par value; 51,500,000 shares authorized, 15,398,368 shares issued and 15,296,735 shares outstanding at March 31, 2022; 12,898,144 shares issued and 12,824,190 shares outstanding at March 31, 2021 15 13
Additional paid-in capital 946,969 934,381
Accumulated deficit (939,482) (919,271)
Treasury stock, at cost; 101,633 shares at March 31, 2022 and 73,954 shares at March 31, 2021 (2,088) (1,949)
Total stockholders' equity 5,414 13,174
Total liabilities and stockholders' equity $ 100,773 $ 106,022